Defining the Ideal Time Interval between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer

BACKGROUND: Induction therapy leads to significant improvement in survival for selected patients with Stage IIIA non-small cell lung cancer (NSCLC). The ideal time interval between induction therapy and surgery remains unknown. METHODS: Clinical Stage IIIA NSCLC patients receiving induction therapy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Thorac Surg
Autori principali: Samson, Pamela, Crabtree, Traves D., Robinson, Cliff G., Morgensztern, Daniel, Broderick, Stephen, Krupnick, A. Sasha, Kreisel, Daniel, Patterson, G. Alexander, Meyers, Bryan, Puri, Varun
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444908/
https://ncbi.nlm.nih.gov/pubmed/28110809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2016.09.053
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi